Dyslipidemia is an Independent Predictor of Rapid Progressive Disease in Patientswith Chronic Liver Disease
Muhammad Yahya Memon, Gohar Ali, Syeda Iffat Bukhari, Nabiya Sandeelo, Haris Alvi, Abu Talib, Paras Imran, Imtiaz Baloch & Syed Zulfiquar Ali Shah · Journal of Pharmaceutical Research International · 2022
Introduction: In chronic liver disease (CLD), the lipid profile biomarkers are altered because of decreased lipoprotein biosynthetic capacity. Objectives: To identify the association of dyslipidemia with various characteristics in chronic liver disease patients. Patients and meth...
Open access
Research Article
10.9734/jpri/2022/v34i37A36194